Iovance Biotherapeutics, Inc. (IOVA)
3.75
+0.13
(+3.59%)
USD |
NASDAQ |
Mar 25, 16:00
3.69
-0.06
(-1.60%)
Pre-Market: 09:20
Iovance Biotherapeutics Free Cash Flow : -336.24M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Orthofix Medical, Inc. | -1.319M |
| InfuSystem Holdings, Inc. | 23.85M |
| Axogen, Inc. | -4.782M |
| KalVista Pharmaceuticals, Inc. | -- |
| Lantheus Holdings, Inc. | 348.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.56M |
| Cash from Investing (Quarterly) | 0.775M |
| Cash from Financing (Quarterly) | 56.17M |
| Free Cash Flow Per Share (Quarterly) | -0.1521 |
| Free Cash Flow to Equity (Quarterly) | -58.84M |
| Free Cash Flow to Firm (Quarterly) | -61.88M |
| Free Cash Flow Yield | -25.11% |